Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.97 SEK -5.52%
Market Cap: 558.9m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Moberg Pharma AB (publ)
Total Liabilities & Equity Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Total Liabilities & Equity
kr634.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Liabilities & Equity
kr1.7B
CAGR 3-Years
14%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Liabilities & Equity
kr3.4B
CAGR 3-Years
49%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Liabilities & Equity
kr10B
CAGR 3-Years
56%
CAGR 5-Years
136%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Total Liabilities & Equity
kr177.1m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Liabilities & Equity
kr4.4B
CAGR 3-Years
107%
CAGR 5-Years
142%
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Total Liabilities & Equity?
Total Liabilities & Equity
634.7m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Total Liabilities & Equity amounts to 634.7m SEK.

What is Moberg Pharma AB (publ)'s Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
10%

Over the last year, the Total Liabilities & Equity growth was 12%. The average annual Total Liabilities & Equity growth rates for Moberg Pharma AB (publ) have been 10% over the past three years .

Back to Top